Goodbody Health Limited
GDBYF
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 21.65M | 26.34M | 28.40M | 23.36M | 14.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.65M | 26.34M | 28.40M | 23.36M | 14.73M |
| Cost of Revenue | 10.99M | 12.99M | 13.64M | 11.12M | 6.78M |
| Gross Profit | 10.66M | 13.35M | 14.76M | 12.24M | 7.95M |
| SG&A Expenses | 12.09M | 13.29M | 13.69M | 12.30M | 10.23M |
| Depreciation & Amortization | 855.20K | 1.04M | 1.27M | 1.44M | 1.36M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.94M | 27.32M | 28.61M | 24.86M | 18.37M |
| Operating Income | -2.29M | -982.20K | -206.10K | -1.50M | -3.64M |
| Income Before Tax | -4.60M | -3.11M | -1.85M | -3.07M | -3.76M |
| Income Tax Expenses | 98.10K | 98.10K | 199.70K | 91.20K | 0.00 |
| Earnings from Continuing Operations | -4.70 | -3.20 | -2.05 | -3.16 | -3.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.70M | -3.20M | -2.05M | -3.16M | -3.76M |
| EBIT | -2.29M | -982.20K | -206.10K | -1.50M | -3.64M |
| EBITDA | -1.70M | -137.30K | 939.00K | -127.40K | -2.48M |
| EPS Basic | -0.13 | -0.09 | -0.06 | -0.10 | -0.12 |
| Normalized Basic EPS | -0.06 | -0.03 | -0.01 | -0.04 | -0.08 |
| EPS Diluted | -0.13 | -0.09 | -0.06 | -0.10 | -0.12 |
| Normalized Diluted EPS | -0.06 | -0.03 | -0.01 | -0.04 | -0.08 |
| Average Basic Shares Outstanding | 145.98M | 145.95M | 144.71M | 138.47M | 132.36M |
| Average Diluted Shares Outstanding | 145.98M | 145.95M | 144.71M | 138.47M | 132.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |